Zelai He

764 total citations
40 papers, 550 citations indexed

About

Zelai He is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zelai He has authored 40 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zelai He's work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (6 papers) and Lung Cancer Research Studies (6 papers). Zelai He is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (6 papers) and Lung Cancer Research Studies (6 papers). Zelai He collaborates with scholars based in China and United States. Zelai He's co-authors include Huijun Zhang, Yufeng Wu, Jingwen Huang, Xiangyu Zhang, Xiangyu Zhang, Wenjie Sun, Ying Sun, Xi Zhang, Can Huang and Yuanyuan Xu and has published in prestigious journals such as Nano Letters, Biochemical and Biophysical Research Communications and The Journal of Physical Chemistry C.

In The Last Decade

Zelai He

37 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zelai He China 16 171 166 162 149 92 40 550
Marco Soster Italy 11 201 1.2× 121 0.7× 81 0.5× 195 1.3× 73 0.8× 15 597
Maike Baues Germany 10 143 0.8× 150 0.9× 102 0.6× 218 1.5× 55 0.6× 11 576
Kun‐Lung Chuang Taiwan 8 148 0.9× 127 0.8× 156 1.0× 101 0.7× 70 0.8× 13 429
Hillevi Bauer United States 11 200 1.2× 171 1.0× 101 0.6× 106 0.7× 119 1.3× 21 560
Youqiang Fang China 11 200 1.2× 80 0.5× 114 0.7× 94 0.6× 72 0.8× 32 467
Luwen Zhu China 12 274 1.6× 161 1.0× 103 0.6× 283 1.9× 55 0.6× 18 687
Wen Song China 11 226 1.3× 88 0.5× 96 0.6× 108 0.7× 48 0.5× 34 500
Meng-jun Qiu China 13 174 1.0× 70 0.4× 102 0.6× 188 1.3× 107 1.2× 28 535
Sujun Han China 8 151 0.9× 69 0.4× 115 0.7× 172 1.2× 82 0.9× 25 455

Countries citing papers authored by Zelai He

Since Specialization
Citations

This map shows the geographic impact of Zelai He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelai He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelai He more than expected).

Fields of papers citing papers by Zelai He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelai He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelai He. The network helps show where Zelai He may publish in the future.

Co-authorship network of co-authors of Zelai He

This figure shows the co-authorship network connecting the top 25 collaborators of Zelai He. A scholar is included among the top collaborators of Zelai He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zelai He. Zelai He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Qiu, Yu, Rong Liu, Shanshan Huang, et al.. (2025). OTUB2 promotes proliferation and metastasis of triple-negative breast cancer by deubiquitinating TRAF6. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(5). 1135–1147. 1 indexed citations
3.
Liu, Yang, et al.. (2025). Impacts of sarcopenia on adverse events and prognosis in Chinese patients with esophageal cancer undergoing chemoradiotherapy. Frontiers in Nutrition. 12. 1523674–1523674. 2 indexed citations
4.
Yin, Yuan, et al.. (2025). Primary cardiac angiosarcoma: a case report. Frontiers in Oncology. 15. 1575207–1575207.
6.
He, Zelai, et al.. (2024). Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in lung adenocarcinoma. Journal of Translational Medicine. 22(1). 216–216. 2 indexed citations
7.
Zhang, Xiangyu & Zelai He. (2023). Cell Membrane Coated pH-Responsive Intelligent Bionic Delivery Nanoplatform for Active Targeting in Photothermal Therapy. International Journal of Nanomedicine. Volume 18. 7729–7744. 5 indexed citations
8.
Li, Tingting, Yong Tian, Yixuan Wang, et al.. (2022). Kiss1 Inhibits the Proliferation of Nasopharyngeal Carcinoma Cells Via Activation of the LKB1/AMPK Pathway. Frontiers in Oncology. 11. 724251–724251. 9 indexed citations
9.
Zhang, Huijun, Ying Li, Xiaofeng Chen, & Zelai He. (2022). Comparison of hook-wire and medical glue for CT-guided preoperative localization of pulmonary nodules. Frontiers in Oncology. 12. 922573–922573. 15 indexed citations
10.
Zhang, Huijun, et al.. (2020). Giant mediastinal liposarcoma resected by median sternotomy: a case report. Translational Cancer Research. 9(10). 6522–6527. 3 indexed citations
11.
Zheng, Xuan-Qi, Xiao Li, Minqi Wang, et al.. (2020). Second primary malignancies among cancer patients. Annals of Translational Medicine. 8(10). 638–638. 20 indexed citations
12.
Zhang, Qi, et al.. (2019). Radiotherapy for recurrent central Giant cell granuloma: a case report. Radiation Oncology. 14(1). 130–130. 6 indexed citations
13.
He, Zelai, Huijun Zhang, Zhe Zhang, et al.. (2019). A case of chemorefractory metastatic type AB thymoma sensitive to helical tomotherapy. Annals of Translational Medicine. 7(12). 274–274. 1 indexed citations
14.
Sun, Qian, Min Li, Hongbo Xu, et al.. (2019). Distribution of metastasis in the brain in relation to the hippocampus: a retrospective single-center analysis of 565 metastases in 116 patients. Cancer Imaging. 19(1). 2–2. 12 indexed citations
15.
Zhang, Xiangyu, et al.. (2019). <p>Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer</p>. Drug Design Development and Therapy. Volume 13. 1357–1372. 37 indexed citations
16.
Zhang, Huijun, Yulong Tan, Shaohua Wang, et al.. (2019). NCBP1 promotes the development of lung adenocarcinoma through up‐regulation of CUL4B. Journal of Cellular and Molecular Medicine. 23(10). 6965–6977. 30 indexed citations
18.
He, Zelai, Qi Wang, Ying Sun, et al.. (2014). The biocompatibility evaluation of mPEG-PLGA-PLL copolymer and different LA/GA ratio effects for biocompatibility. Journal of Biomaterials Science Polymer Edition. 25(9). 943–964. 23 indexed citations
19.
He, Zelai, Daniel J. Leong, Justin Tang, et al.. (2013). A Novel Regulatory Role of CITED2 in Non-Small Cell Lung Cancer (NSCLC) Stem Cells and in Modulating the Effect of HDACi Treatment on NSCLC. International Journal of Radiation Oncology*Biology*Physics. 87(2). S662–S662. 2 indexed citations
20.
Huang, Yuli, Guohui Fan, Jian‐Qiang Zhong, et al.. (2013). Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China. Herz. 38(7). 779–784. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026